Form 4: Elanco GC O'Neill Reports Routine Stock Disposition

Elanco Animal Health Inc.'s General Counsel and Corporate Secretary, Shiv O'Neill, reported a disposition of 4,738 common shares at $24.88 each, primarily for tax liability.

Summary

• Shiv O'Neill, General Counsel and Corporate Secretary of Elanco Animal Health Inc., reported a transaction involving the company's common stock.
• On March 3, 2026, O'Neill disposed of 4,738 shares of common stock.
• The transaction was executed at a price of $24.88 per share.
• This disposition was coded as "F," indicating it was a payment of an exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise, or vesting of a security.
• Following this transaction, O'Neill beneficially owns 83,834 shares of common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine, non-discretionary transaction for tax purposes, common for executives receiving equity compensation, and does not reflect a change in company fundamentals or insider sentiment.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent disposition, often for tax purposes.

Negatives

• No specific negative aspects are indicated by this routine tax-related disposition.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, particularly those marked as dispositions for tax purposes under a 10b5-1 plan, are common occurrences in publicly traded companies and generally do not signal significant shifts in company strategy or performance. Such filings are standard disclosures for executive compensation.

Comparison to Industry Standards

• This type of transaction (disposition for tax liability) is a standard practice for executives receiving equity compensation across various industries, including the animal health sector. It aligns with typical compensation structures where restricted stock units or options vest, triggering tax obligations that are often met by withholding a portion of the shares.
• Compared to other large pharmaceutical or animal health companies like Zoetis Inc. (ZTS) or Merck Animal Health (MRK), similar Form 4 filings are regularly observed for their executives, reflecting the common use of equity-based compensation.

Corporate Governance

Related Party Transactions

• This Form 4 reports an insider transaction where a corporate officer (Shiv O'Neill) disposed of company stock, which is inherently a related party transaction as defined by SEC regulations.
• The disposition was to the issuer for tax liability, a common form of related party transaction in executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in the executive's confidence or company performance.
• Employees: No direct impact indicated.
• Customers/Suppliers/Creditors: No direct impact indicated.

Key Dates

Keywords

Elanco Animal Health, ELAN, Shiv O'Neill, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Corporate Governance, SEC Filing, Rule 10b5-1